Replies to post #10339 on ANI Pharmaceuticals (ANIP)

[dasgrunt]

so moving forward with corti , assuming a launch date in july, 5 months of sales for 2020

per art "I've described Cortrophin Gel as a potential $200 million free cash flow opportunity for ANI. "

by the end of 2020 no debt

revenue estimate for 2021 600 million ? with 280 million ebitda

whats the market cap for a company like that